Search Result "FMO3"
Genetic Polymorphism of the Flavin-Containing Monooxygenase 3 (FMO3) Associated with Trimethylaminuria (Fish Odor Syndrome): Observations from Japanese Patients
Journal: Current Drug Metabolism
Volume: 8 Issue: 5 Year: 2007 Page: 487-491
Author(s): Hiroshi Yamazaki, Makiko Shimizu
Analysis of Flavin-Containing Monooxygenase 3 Genotype Data in Populations Administered the Anti-Schizophrenia Agent Olanzapine
Journal: Drug Metabolism Letters
Volume: 2 Issue: 2 Year: 2008 Page: 100-114
Author(s): John R. Cashman, Jun Zhang, Matthew R. Nelson, Andreas Braun
Human Flavin-Containing Monooxygenase Substrate Specificity and Role in Drug Metabolism
Journal: Current Drug Metabolism
Volume: 1 Issue: 2 Year: 2000 Page: 181-191
Author(s): J. R. Cashman
The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs
Journal: Current Pharmacogenomics
Volume: 5 Issue: 4 Year: 2007 Page: 292-313
Author(s): Ian R. Phillips, Asvi A. Francois, Elizabeth A. Shephard
Trimethylamine: Metabolic, Pharmacokinetic and Safety Aspects
Journal: Current Drug Metabolism
Volume: 6 Issue: 3 Year: 2005 Page: 227-240
Author(s): Marcus A. Bain, Gianfranco Fornasini, Allan M. Evans
Biochemical and Clinical Aspects of the Human Flavin-Containing Monooxygenase Form 3 (FMO3) Related to Trimethylaminuria
Journal: Current Drug Metabolism
Volume: 4 Issue: 2 Year: 2003 Page: 151-170
Author(s): John R. Cashman, Kathryn Camp, Steven S. Fakharzadeh, Paul V. Fennessey, Ronald N. Hines, Orval A. Mamer, Steven C. Mitchell, George Preti, Daniel Schlenk, Robert L. Smith
Different Effects of Polymorphic Flavin-Containing Monooxygenase 3 and Cytochrome P450 2A6 Activities on an Index of Arteriosclerosis as a Lifestyle-Related Disease in a General Population in Japan
Journal: Current Drug Metabolism
Volume: 21 Issue: 14 Year: 2020 Page: 1161-1164
Author(s): Mirai Uraoka,Makiko Shimizu,Yoshiki Kuwajima,Ami Mizugaki,Haruka Yokoyama,Kanae Mure,Hiroshi Yamazaki
Pharmacogenetic Variants Can Influence Optical Medication Use
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 24 Issue: 16 Year: 2024 Page: 5-5
Author(s):
Human Liver Enzymes Responsible for Metabolic Elimination of Tyramine, a Vasopressor Agent from Daily Food
Journal: Drug Metabolism Letters
Volume: 5 Issue: 3 Year: 2011 Page: 216-219
Author(s): Toshiro Niwa, Norie Murayama, Hiromi Umeyama, Makiko Shimizu, Hiroshi Yamazaki
Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential AtherosclerosisTreatment Strategies
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 35 Year: 2022 Page: 2914-2919
Author(s):